Pricing Log in Create free account

Retension Pharmaceuticals, Inc. (RTSN) vs vTv Therapeutics Inc. (VTVT)

Retension Pharmaceuticals, Inc. and vTv Therapeutics Inc. are both Biotechnology companies. Retension Pharmaceuticals, Inc. and vTv Therapeutics Inc. are of similar size ($96.6M and $95.0M).

Valuation

Metric RTSN VTVT Biotechnology median
P/E — n/m 10.26
P/S — 7.15 9.18
P/B — 3.44 2.05
Price to free cash flow — n/m 24.81
EV/EBITDA — n/m 0.65
EV/Sales — 4.90 8.98
Earnings yield — (3.53%) (34.89%)
Free cash flow yield — (6.23%) (24.52%)

Profitability

Metric RTSN VTVT Biotechnology median
Gross margin — 99.92% 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — (11.74%) (50.12%)
Return on assets — (8.34%) (45.60%)
Return on invested capital — 0.00% 0.00%

Growth

Metric RTSN VTVT Biotechnology median
Revenue growth (TTM) — 654.58% 6.26%
EPS growth (last fiscal year) — 0.00% 29.88%
Revenue growth, 5-year CAGR — (39.39%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric RTSN VTVT Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 12.48 4.89
Net debt to EBITDA — 2.71 1.01

Dividend

Metric RTSN VTVT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RTSN VTVT Biotechnology median
Market cap 96.61m 95.02m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack